Volume 2 • Issue 1 • 2011
Review Article
Hormones and receptors in endometrial cancer
- David Bender
- Thomas Buekers
- Kimberly Leslie
Volume 2 • Issue 1 • 2011 • 1–25
Wnt/ß-catenin/Lef-1 signaling in the uterus and its implications in uterine gland formation and cancer development
- Dawne N. Shelton
- Michael J. Goodheart
Volume 2 • Issue 1 • 2011 • 1–11
Article
Toward a microRNA signature of endometrial cancer
- Eric J. Devor
- Michael J. Goodheart
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–7
Case Report
Positron emission tomography in detection of metastatic leiomyosarcoma in a postoperative patient: a case report
- David B Engle
- Linda M. Smiley
- Scott L. Baum
- Greg P. Wellman
Volume 2 • Issue 1 • 2011 • 1–5
Diagnosis of endometrial cancer complicated by morbid obesity—a case report
- Janna Girardi
- Michael Goodheart
Volume 2 • Issue 1 • 2011 • 1–5
Board Member Spotlight
Abstract
The relationship between vascularity, p53 gene mutations and distant metastatic disease in epithelial ovarian carcinoma
- Janna Girardi
- Megan Samuelson
- Anna Button
- Koen De Geest
- David P. Bender
- Amina Ahmed
- Michael Goodheart
Volume 2 • Issue 1 • 2011 • 1–2
Lymphoid Enhancing Factor 1 (Lef-1) overexpression in epithelial ovarian, fallopian tube and peritoneal cancer and associations with clinical factors
- Aine Clements
- David Engle
- Dawne Shelton
- Traci Neff
- Soo Park
- David Bender
- Amina Ahmed
- Koen De Geest
- Anna Button
- John F. Engelhardt
- Michael Goodheart
Volume 2 • Issue 1 • 2011 • 1–2
Combination therapy with mTOR and PI3 kinase inhibitors is broadly synergistic in a wide variety of endometrial cancer cells
- Shujie Yang
- Xue Xiao
- Xiangbing Meng
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–2
Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer
- David Engle
- Hubert Fornalik
- Traci Neff
- Anna Button
- K Collins
- Amina Ahmed
- David Bender
- Susan Lutgendorf
- Michael Goodheart
Volume 2 • Issue 1 • 2011 • 1–2
Zmiz1 is overexpressed in epithelial ovarian cancer and associated with p53 gene mutations
- Niyati J Nadkarni
- Laura M. Rogers
- Megan Samuelson
- Traci Neff
- David P. Bender
- Amina Ahmed
- Koen De Geest
- Anna Button
- Adam Dupuy
- Michael Goodheart
Volume 2 • Issue 1 • 2011 • 1–2
MiR-888: A newly identified miRNA significantly over-expressed in endometrial cancers
- Adriann M. Hovey
- Eric J. Devor
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–1
Knockdown of MTDH increases drug sensitivity to HDAC inhibitor and TRAIL combination treatment in endometrial cancer cells
- Xiangbing Meng
- Pavla Brachova
- Shujie Yang
- Zhi Xiong
- Yuping Zhang
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–2
H19/miR-675 non-coding RNA expression differentiates among cancers of the human endometrium.
- Eric J Devor
- Jill N. DeMik
- Brandon M. Schickling
- Michael J. Goodheart
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–1
The combination of Paclitaxel and Gefitinib inhibits endometrial cancer cells by inducing mitotic catastrophe: proof of principle for dual therapy in endometrial cancer
- Xiangbing Meng
- Laura L. Laidler
- Lina Albitar
- Anna M. Holmes
- Donghai Dai
- Thomas E. Buekers
- David P. Bender
- Kimberly K. Leslie
Volume 2 • Issue 1 • 2011 • 1–2